Effect of the Extracorporeal Shock Wave Therapy (ESWT) in Chronic Low Back Pain

Comparison of the Effect of Classical Physical Therapy Agents and Extracorporeal Shock Wave Therapy (ESWT) on Pain, Disability, Functional Status and Depression in Patients with Chronic Low Back Pain; Prospective randomized controlled trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190411043240N1

Enrollment

Registered

2019-05-23

Start date

2019-07-20

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic low back pain. Low back pain

Interventions

Intervention 1: Intervention group: extracorporeal shock wave therapy. The model name of the device is Modus ESWT. Device has CE ("Conformité Européene") mark. The global product (barcode) number is

ESWT is routinely applied in achilles tendinopathy and plantar fasciitis.Shock waves promote axonal regeneration of peripheral nerves by various molecular reactions.ESWT has been reported to induce an

There are few studies on the effects of low back pain on pain, disability and depression.ESWT will be applied in a total of 5 sessions 2-3 weeks after a minimum of 2 days. After the application of the

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Male and female patients with low back pain who have been diagnosed with chronic low back pain for at least 3 months between 18- 65 years old Patients who are able to understand correctly the patient information form and cooperate Patients consenting to participate in the study according to the informed consent form

Exclusion criteria

Exclusion criteria: Operational history of lumbar spine region. Vertebral compression fracture Spinal tumors Intervertebral disc infections Inflammatory rheumatic disease Pregnant patients Heart disease Structural abnormalities Whether the patient is unwilling or unable to participate for any reason Deciding whether the clinician does not benefit the patient

Design outcomes

Primary

Measure	Time frame
The Beck Depression Scale will be used to determine the levels of depression, and Oswestry, Health Assessment Questionnaire (Haq). Visual analogue scale (VAS) and Algometer will be used to question the pain status in individuals. Timepoint: before treatment, after treatment and at 3rd month. Method of measurement: The Beck Depression Scale will be used to determine the levels of depression, and Oswestry, Health Assessment Questionnaire (Haq). Visual analogue scale (VAS) and Algometer will be used to question the pain status in individuals.	—

Measure

Time frame

The Beck Depression Scale will be used to determine the levels of depression, and Oswestry, Health Assessment Questionnaire (Haq). Visual analogue scale (VAS) and Algometer will be used to question the pain status in individuals. Timepoint: before treatment, after treatment and at 3rd month. Method of measurement: The Beck Depression Scale will be used to determine the levels of depression, and Oswestry, Health Assessment Questionnaire (Haq). Visual analogue scale (VAS) and Algometer will be used to question the pain status in individuals.

—

Countries

Turkey

Contacts

Public ContactMehmet Okcu

Ahi evran university

mehmet.okcu@ahievran.edu.tr+90 386 441 02 44

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026